Nucleate Podcast

Generative AI for Novel Therapies | Sean McClain, Absci

May 6, 2024
Guest
Sean McClain
Sean McClain, Founder and CEO of AbSci, discusses using AI for drug development, the fusion of engineering and biology, the power of mentors in entrepreneurship, fostering diverse perspectives in leadership teams, and the challenges of pivoting to generative AI for antibodies.
Ask episode
Chapters
Transcript
Episode notes
1
Introduction
00:00 • 2min
2
Engineering Biology: AI's Revolution in Antibody Design
01:41 • 20min
3
The Power of Mentors in Entrepreneurial Growth
21:52 • 11min
4
Fostering Contrarian Views in Leadership Teams
32:49 • 5min
5
Pivoting to Generative AI for Antibodies
37:27 • 7min
6
Navigating Team Alignment Challenges and Strategic Shifts
44:28 • 2min
7
Navigating Entrepreneurial Challenges
46:15 • 7min